IP Library Granted Patent US 11,821,902
Granted Patent B2
US 11,821,902 · App. 16/936,848 · Granted Nov 21, 2023

Quantitative peptide or protein assay

Inventors: Paul Jeffrey Haney (Beloit, WI); Christopher L. Etienne (Oregon, WI); Sijian Hou (Rockford, IL); Erum Raja (Rockford, IL); Ramesh Ganapathy (Loves Park, IL)
Assignee: Pierce Biotechnology, Inc.
G01N33/6833G01N33/6839G01N2560/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,821,902
App. No.
16/936,848
Granted
Nov 21, 2023
Kind
B2
Abstract

Peptide and/or protein quantitation methods, kits, and compositions, particularly useful for mass spectrometry, are provided herein based on a bathocuproine-based composition complex such as bathocuproinedisulfonic acid disodium salt hydrate complex. The methods are one-step rapid absorbance methods using small sample volumes. They produce a robust signal with high signal to background ratio and accurately quantitate even complex peptide mixtures with low variability and high sensitivity.

Claims (21)

1. A kit for protein or peptide quantitation of a sample comprising:

(a) a reagent composition comprising sodium carbonate;

(b) a reagent composition comprising acetonitrile and a complex having the formula:

wherein

each of R 1 and R 2 is independently chosen from C 1 -C 6 straight and branched alkyls, C 6 -C 20 aryl, alkylaryl, and arylalkyls;

each of R 3 and R 4 is independently chosen from the group consisting of hydrogen; sulfonate salts chosen from sodium, potassium, and lithium; phosphonate salts chosen from sodium, potassium, and lithium; and carboxylate salts chosen from sodium, potassium, and lithium; and

each of R 5 and R 6 is

 wherein R 7 is independently chosen from the group consisting of hydrogen; sulfonate salts chosen from sodium, potassium, and lithium; phosphonate salts chosen from sodium, potassium, and lithium; and carboxylate salts chosen from sodium, potassium, and lithium;

with the proviso that at least one of R 3 , R 4 , and R 7 is not H;

(c) a reagent composition comprising copper sulfate; and

(d) instructions for the peptide quantitation determination, wherein the determination comprises combining the components (a), (b), and (c) with the sample to form a colored complex, wherein acetonitrile is present in the combination at a concentration ranging from about 10% to about 50%, wherein the kit does not contain an additional reducing agent to reduce excess Cu 2+ to Cu 1+ , and wherein the concentration of peptide or protein in said sample is directly proportional to the amount of colored complex that forms once the sample and components are mixed.

2. The kit of claim 1 , wherein the complex is present in the combination at a concentration ranging from about 0.04 M to about 0.1 M.

3. The kit of claim 1 , wherein each of R 1 and R 2 is independently chosen from methyl, ethyl, propyl, butyl, and phenyl.

4. The kit of claim 1 , wherein the kit further comprises (e) an internal standard chosen from peptides, peptide mixtures, and protein digests.

5. The kit of claim 1 , wherein the complex has the formula:

6. The kit of claim 5 , wherein the acetonitrile is present at a concentration ranging from about 10% to about 30%.

7. The kit of claim 1 , wherein the copper sulfate is present at a concentration ranging from about 0.25 M to about 0.5 M.

8. The kit of claim 1 , wherein the reagent composition of (a) further comprises tartrate.

9. The kit of claim 8 , wherein the tartrate is present at a concentration ranging from about 5.7 mM to about 22.7 mM.

10. The kit of claim 8 , where the tartrate is sodium tartarate.

11. The kit of claim 1 , wherein the reagent composition of (a) further comprises sodium bicarbonate.

Assignments (2)
MERGER Recorded Mar 11, 2026
From: PIERCE BIOTECHNOLOGY, INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 075052/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: HANEY, PAUL JEFFREY; ETIENNE, CHRISTOPHER L.; HOU, SIJIAN; RAJA, ERUM; GANAPATHY, RAMESH
To: PIERCE BIOTECHNOLOGY, INC.
Reel/Frame 053994/0705 →
Continuity (5)
Division 16299667 · Mar 12, 2019
Division 15674831 · Aug 11, 2017
Division 14734678 · Jun 9, 2015
Provisional Application 62010594 · Jun 11, 2014
Related Publication 20210003584A1 · Jan 7, 2021